Specialists for Renal cell carcinoma

29 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Ivan Pedrosa, MD, PhD, M.D
Rare Disease / Clinical Research
University of Texas Southwestern Medical Center
HOUSTON, TX
QC-verified PI×1
Marine Gross-Goupil
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute
QC-verified 3
Jae Lyun Lee
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute
QC-verified 2
Camillo Porta
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute
QC-verified 3
Thomas Powles
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute
QC-verified PI×1 6
Bohuslav Melichar
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute
QC-verified 4
Stefan N Symeonides
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute and Harvard Medical School (T.K.C.) and Beth Israel Deaconess Medical Center (D.F.M.) - all in Boston; Poznan University of Medical Sciences
QC-verified 2
Piotr Tomczak
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute and Harvard Medical School (T.K.C.) and Beth Israel Deaconess Medical Center (D.F.M.) - all in Boston; Poznan University of Medical Sciences
QC-verified 2
Yen-Hwa Chang
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute and Harvard Medical School (T.K.C.) and Beth Israel Deaconess Medical Center (D.F.M.) - all in Boston; Poznan University of Medical Sciences
QC-verified 2
Jaroslav Hajek
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute and Harvard Medical School (T.K.C.) and Beth Israel Deaconess Medical Center (D.F.M.) - all in Boston; Poznan University of Medical Sciences
QC-verified 2
Rodolfo F Perini, MD
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute
PHILADELPHIA, PA
QC-verified 4
Howard Gurney
Rare Disease / Clinical Research
From Memorial Sloan Kettering Cancer Center
QC-verified 3
Balaji Venugopal
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute
QC-verified 3
Se Hoon Park
Rare Disease / Clinical Research
From Dana-Farber Cancer Institute
DOWNEY, CA
QC-verified 3
David A Braun
Rare Disease / Clinical Research
Yale School of Medicine
QC-verified 3
Eric Jonasch, MD, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×15
Daniel George, MD
Rare Disease / Clinical Research
Duke University
PI×4
Giuseppe Procopio, MD, R. Ph
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
PI×10 1
David Maloney
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
PI×11
Robert J Amato, MD
Rare Disease / Clinical Research
The Methodist Hospital Research Institute
PI×1
Andrea B Apolo
Rare Disease Specialist
National Cancer Institute LAO
Birmingham, Alabama
PI×4
Mark Jones, MD
Rare Disease / Clinical Research
Incyte Corporation
PI×6
Kan Gong
Peking University First Hospital
PI×3 9
Selman Unal
Rare Disease / Clinical Research
Ankara Yildirim Beyazit University School of Medicine, Department of Urology
PI×1 53
Eisai Medical Services
Rare Disease / Clinical Research
Eisai Limited
PI×3
Abdul Naqash, MD, MD
Rare Disease / Clinical Research
University of Oklahoma
OKLAHOMA CITY, OK
PI×1 1
Robert J Amato, DO
Rare Disease / Clinical Research
Baylor College of Medicine - Methodist Hospital
PI×8 6
Chad G Rusthoven
Rare Disease Specialist
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Andrei M Iagaru, MD, MD
Rare Disease / Clinical Research
Stanford University
STANFORD, CA
PI×1 1

More about Renal cell carcinoma